2/3/25 20:03 | 1/31/25 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 11 | 1.86 | 0 | 6 | 22 | 33 | D | | | | | | | | | | | | | | |
2/3/25 20:03 | 1/31/25 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -115 | 19.95 | 0 | -6 | -15 | 33 | D | | | | | | | | | | | | | | |
1/30/25 19:53 | 1/30/25 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 8 | 31 | 33 | D | | | | | | | | | | | | | | |
1/30/25 19:53 | 1/30/25 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -64 | 19.85 | 0 | -3 | -9 | 33 | D | | | | | | | | | | | | | | |
1/30/25 19:48 | 1/30/25 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 9 | 19 | 56 | D | | | | | | | | | | | | | | |
1/30/25 19:48 | 1/30/25 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -73 | 19.85 | 0 | -4 | -6 | 56 | D | | | | | | | | | | | | | | |
1/30/25 19:43 | 1/30/25 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 9 | 28 | 40 | D | | | | | | | | | | | | | | |
1/30/25 19:43 | 1/30/25 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -56 | 19.85 | 0 | -3 | -7 | 40 | D | | | | | | | | | | | | | | |
1/2/25 17:28 | 1/2/25 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 11 | 1.86 | 0 | 6 | 26 | 28 | D | | | | | | | | | | | | | | |
1/2/25 17:28 | 1/2/25 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -112 | 19.50 | 0 | -6 | -17 | 28 | D | | | | | | | | | | | | | | |
12/2/24 18:00 | 12/2/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 11 | 1.86 | 0 | 6 | 26 | 28 | D | | | | | | | | | | | | | | |
12/2/24 18:00 | 12/2/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -125 | 21.73 | 0 | -6 | -17 | 28 | D | | | | | | | | | | | | | | |
11/4/24 17:48 | 11/4/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 31 | 9.57 | 0 | 3 | 13 | 28 | D | | | | | | | | | | | | | | |
11/4/24 17:48 | 11/4/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -82 | 25.00 | 0 | -3 | -10 | 28 | D | | | | | | | | | | | | | | |
11/1/24 17:57 | 11/1/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 11 | 1.86 | 0 | 6 | 26 | 28 | D | | | | | | | | | | | | | | |
11/1/24 17:57 | 11/1/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -140 | 24.28 | 0 | -6 | -17 | 28 | D | | | | | | | | | | | | | | |
11/1/24 17:57 | 11/1/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S | -86 | 24.28 | 0 | -4 | -10 | 34 | D | | | | | | | | | | | | | | |
10/30/24 20:30 | 10/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 9 | 30 | 37 | D | | | | | | | | | | | | | | |
10/30/24 20:30 | 10/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -58 | 24.31 | 0 | -2 | -6 | 37 | D | | | | | | | | | | | | | | |
10/30/24 20:30 | 10/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 9 | 21 | 51 | D | | | | | | | | | | | | | | |
10/30/24 20:30 | 10/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -84 | 24.31 | 0 | -3 | -6 | 51 | D | | | | | | | | | | | | | | |
10/30/24 20:30 | 10/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 8 | 38 | 28 | D | | | | | | | | | | | | | | |
10/30/24 20:30 | 10/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -102 | 24.31 | 0 | -4 | -13 | 28 | D | | | | | | | | | | | | | | |
10/15/24 09:16 | 10/14/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 31 | 9.57 | 0 | 3 | 15 | 25 | D | | | | | | | | | | | | | | |
10/15/24 09:16 | 10/14/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -82 | 25.00 | 0 | -3 | -12 | 25 | D | | | | | | | | | | | | | | |
10/1/24 19:36 | 10/1/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 11 | 1.86 | 0 | 6 | 31 | 25 | D | | | | | | | | | | | | | | |
10/1/24 19:36 | 10/1/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -128 | 22.23 | 0 | -6 | -19 | 25 | D | | | | | | | | | | | | | | |
9/3/24 17:33 | 9/3/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 42 | 4.66 | 0 | 9 | 58 | 25 | D | | | | | | | | | | | | | | |
9/3/24 17:33 | 9/3/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -226 | 24.94 | 0 | -9 | -27 | 25 | D | | | | | | | | | | | | | | |
8/26/24 18:23 | 8/26/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 60 | 6.08 | 0 | 10 | 67 | 25 | D | | | | | | | | | | | | | | |
8/26/24 18:23 | 8/26/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -247 | 25.01 | 0 | -10 | -29 | 25 | D | | | | | | | | | | | | | | |
8/26/24 17:41 | 8/26/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S | -504 | 25.22 | 0 | -20 | -39 | 31 | D | | | | | | | | | | | | | | |
8/1/24 19:06 | 8/1/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S | -75 | 21.45 | 0 | -3 | -6 | 51 | D | | | | | | | | | | | | | | |
8/1/24 19:06 | 8/1/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 11 | 1.86 | 0 | 6 | 31 | 25 | D | | | | | | | | | | | | | | |
8/1/24 19:06 | 8/1/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -123 | 21.43 | 0 | -6 | -19 | 25 | D | | | | | | | | | | | | | | |
7/30/24 19:06 | 7/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 9 | 25 | 45 | D | | | | | | | | | | | | | | |
7/30/24 19:06 | 7/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -70 | 20.67 | 0 | -3 | -7 | 45 | D | | | | | | | | | | | | | | |
7/30/24 19:06 | 7/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 8 | 45 | 25 | D | | | | | | | | | | | | | | |
7/30/24 19:06 | 7/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -60 | 20.67 | 0 | -3 | -11 | 25 | D | | | | | | | | | | | | | | |
7/30/24 19:06 | 7/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 9 | 19 | 54 | D | | | | | | | | | | | | | | |
7/30/24 19:06 | 7/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -51 | 20.67 | 0 | -2 | -4 | 54 | D | | | | | | | | | | | | | | |
7/1/24 18:35 | 7/1/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 11 | 1.86 | 0 | 6 | 41 | 20 | D | | | | | | | | | | | | | | |
7/1/24 18:35 | 7/1/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -120 | 20.81 | 0 | -6 | -23 | 20 | D | | | | | | | | | | | | | | |
6/20/24 16:58 | 6/20/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S | -400 | 20.01 | 0 | -20 | -29 | 48 | D | | | | | | | | | | | | | | |
6/13/24 18:39 | 6/13/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 3 | 1.86 | 0 | 2 | 10 | 20 | D | | | | | | | | | | | | | | |
6/13/24 18:39 | 6/13/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -32 | 17.02 | 0 | -2 | -9 | 20 | D | | | | | | | | | | | | | | |
6/12/24 19:30 | 6/12/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 4 | 1.86 | 0 | 2 | 11 | 20 | D | | | | | | | | | | | | | | |
6/12/24 19:30 | 6/12/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -32 | 17.01 | 0 | -2 | -9 | 20 | D | | | | | | | | | | | | | | |
6/5/24 18:01 | 6/5/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 1 | 1.86 | 0 | 0 | 2 | 20 | D | | | | | | | | | | | | | | |
6/5/24 18:01 | 6/5/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -7 | 17.00 | 0 | 0 | -2 | 20 | D | | | | | | | | | | | | | | |
6/3/24 18:36 | 6/3/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 3 | 1.86 | 0 | 2 | 9 | 20 | D | | | | | | | | | | | | | | |
6/3/24 18:36 | 6/3/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -27 | 17.01 | 0 | -2 | -7 | 20 | D | | | | | | | | | | | | | | |
5/2/24 18:01 | 5/2/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S | -45 | 12.83 | 0 | -3 | -5 | 68 | D | | | | | | | | | | | | | | |
4/30/24 18:33 | 4/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 5 | 7 | 72 | D | | | | | | | | | | | | | | |
4/30/24 18:33 | 4/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -17 | 12.04 | 0 | -1 | -2 | 72 | D | | | | | | | | | | | | | | |
4/30/24 18:33 | 4/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 5 | 15 | 40 | D | | | | | | | | | | | | | | |
4/30/24 18:33 | 4/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -24 | 12.04 | 0 | -2 | -5 | 40 | D | | | | | | | | | | | | | | |
4/30/24 18:33 | 4/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 4 | 25 | 20 | D | | | | | | | | | | | | | | |
4/30/24 18:33 | 4/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -18 | 12.04 | 0 | -2 | -7 | 20 | D | | | | | | | | | | | | | | |
2/16/24 19:20 | 2/16/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S | -68 | 10.02 | 0 | -7 | -9 | 68 | D | | | | | | | | | | | | | | |
1/30/24 18:53 | 1/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 5 | 7 | 75 | D | | | | | | | | | | | | | | |
1/30/24 18:53 | 1/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -13 | 7.99 | 0 | -2 | -2 | 75 | D | | | | | | | | | | | | | | |
1/30/24 18:52 | 1/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 5 | 17 | 36 | D | | | | | | | | | | | | | | |
1/30/24 18:52 | 1/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -19 | 7.99 | 0 | -2 | -6 | 36 | D | | | | | | | | | | | | | | |
1/30/24 18:52 | 1/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 4 | 29 | 17 | D | | | | | | | | | | | | | | |
1/30/24 18:52 | 1/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -14 | 7.99 | 0 | -2 | -9 | 17 | D | | | | | | | | | | | | | | |
12/21/23 17:19 | 12/20/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S | -35 | 10.00 | 0 | -4 | -5 | 72 | D | | | | | | | | | | | | | | |
12/20/23 16:55 | 12/19/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S | -109 | 10.00 | 0 | -11 | -13 | 75 | D | | | | | | | | | | | | | | |
11/1/23 16:41 | 10/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 5 | 6 | 86 | D | | | | | | | | | | | | | | |
11/1/23 16:41 | 10/31/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -6 | 5.20 | 0 | -1 | -1 | 86 | D | | | | | | | | | | | | | | |
11/1/23 16:40 | 10/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 4 | 35 | 15 | D | | | | | | | | | | | | | | |
11/1/23 16:40 | 10/31/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -6 | 5.20 | 0 | -1 | -7 | 15 | D | | | | | | | | | | | | | | |
11/1/23 16:40 | 10/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 5 | 18 | 34 | D | | | | | | | | | | | | | | |
11/1/23 16:40 | 10/31/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -8 | 5.20 | 0 | -2 | -5 | 34 | D | | | | | | | | | | | | | | |
8/1/23 16:28 | 7/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 5 | 6 | 83 | D | | | | | | | | | | | | | | |
8/1/23 16:28 | 7/31/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -12 | 9.65 | 0 | -1 | -1 | 83 | D | | | | | | | | | | | | | | |
8/1/23 16:27 | 7/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 4 | 46 | 13 | D | | | | | | | | | | | | | | |
8/1/23 16:27 | 7/31/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -14 | 9.65 | 0 | -1 | -10 | 13 | D | | | | | | | | | | | | | | |
8/1/23 16:26 | 7/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 5 | 21 | 30 | D | | | | | | | | | | | | | | |
8/1/23 16:26 | 7/31/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -18 | 9.65 | 0 | -2 | -6 | 30 | D | | | | | | | | | | | | | | |
5/2/23 16:33 | 4/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | M.d | 0 | 0.00 | 0 | 1 | 19 | 6 | D | | | | | | | | | | | | | | |
5/2/23 16:33 | 5/1/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | S.d | -3 | 9.88 | 0 | 0 | -5 | 6 | D | | | | | | | | | | | | | | |
5/2/23 16:33 | 4/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 3 | 4 | 79 | D | | | | | | | | | | | | | | |
5/2/23 16:33 | 5/1/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -7 | 9.88 | 0 | -1 | -1 | 79 | D | | | | | | | | | | | | | | |
5/2/23 16:32 | 4/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 2 | 24 | 10 | D | | | | | | | | | | | | | | |
5/2/23 16:32 | 5/1/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -7 | 9.88 | 0 | -1 | -6 | 10 | D | | | | | | | | | | | | | | |
5/2/23 16:31 | 4/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 3 | 14 | 27 | D | | | | | | | | | | | | | | |
5/2/23 16:31 | 5/1/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -11 | 9.88 | 0 | -1 | -4 | 27 | D | | | | | | | | | | | | | | |
2/1/23 16:18 | 1/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | M.d | 0 | 0.00 | 0 | 1 | 32 | 4 | D | | | | | | | | | | | | | | |
2/1/23 16:18 | 1/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | S.d | -5 | 11.78 | 0 | 0 | -10 | 4 | D | | | | | | | | | | | | | | |
2/1/23 16:17 | 1/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 3 | 4 | 77 | D | | | | | | | | | | | | | | |
2/1/23 16:17 | 1/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -11 | 11.78 | 0 | -1 | -1 | 77 | D | | | | | | | | | | | | | | |
2/1/23 16:16 | 1/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 2 | 36 | 7 | D | | | | | | | | | | | | | | |
2/1/23 16:16 | 1/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -10 | 11.78 | 0 | -1 | -10 | 7 | D | | | | | | | | | | | | | | |
2/1/23 16:15 | 1/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 3 | 16 | 23 | D | | | | | | | | | | | | | | |
2/1/23 16:15 | 1/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -17 | 11.78 | 0 | -1 | -6 | 23 | D | | | | | | | | | | | | | | |
11/1/22 19:35 | 10/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 3 | 4 | 75 | D | | | | | | | | | | | | | | |
11/1/22 19:35 | 10/31/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -10 | 12.88 | 0 | -1 | -1 | 75 | D | | | | | | | | | | | | | | |
11/1/22 19:34 | 10/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 2 | 45 | 6 | D | | | | | | | | | | | | | | |
11/1/22 19:34 | 10/31/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -9 | 12.88 | 0 | -1 | -10 | 6 | D | | | | | | | | | | | | | | |
11/1/22 19:33 | 10/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 3 | 18 | 21 | D | | | | | | | | | | | | | | |
11/1/22 19:33 | 10/31/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -15 | 12.88 | 0 | -1 | -5 | 21 | D | | | | | | | | | | | | | | |
11/1/22 19:32 | 10/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | M.d | 0 | 0.00 | 0 | 1 | 39 | 3 | D | | | | | | | | | | | | | | |
11/1/22 19:32 | 10/31/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | S.d | -5 | 12.88 | 0 | 0 | -9 | 3 | D | | | | | | | | | | | | | | |
8/2/22 17:50 | 7/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 2 | 71 | 5 | D | | | | | | | | | | | | | | |
8/2/22 17:50 | 8/1/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -11 | 15.67 | 0 | -1 | -13 | 5 | D | | | | | | | | | | | | | | |
8/2/22 17:48 | 7/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | M.d | 0 | 0.00 | 0 | 1 | 349 | 1 | D | | | | | | | | | | | | | | |
8/2/22 17:48 | 8/1/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | S.d | -6 | 15.67 | 0 | 0 | -22 | 1 | D | | | | | | | | | | | | | | |
8/2/22 17:46 | 7/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 3 | 4 | 73 | D | | | | | | | | | | | | | | |
8/2/22 17:46 | 8/1/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -12 | 15.67 | 0 | -1 | -1 | 73 | D | | | | | | | | | | | | | | |
8/2/22 17:45 | 7/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 3 | 20 | 19 | D | | | | | | | | | | | | | | |
8/2/22 17:45 | 8/1/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -19 | 15.67 | 0 | -1 | -6 | 19 | D | | | | | | | | | | | | | | |
6/1/22 16:57 | 5/31/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 57 | 0.8400 | 0 | 68 | 999% | 71 | D | | | | | | | | | | | | | | |
5/3/22 19:05 | 4/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 3 | 23 | 17 | D | | | | | | | | | | | | | | |
5/3/22 19:05 | 5/2/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -13 | 11.75 | 0 | -1 | -6 | 17 | D | | | | | | | | | | | | | | |
5/3/22 19:04 | 4/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | M.d | 0 | 0.00 | 0 | 1 | | 1 | D | | | | | | | | | | | | | | |
5/3/22 19:04 | 5/2/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | S.d | -4 | 11.75 | 0 | 0 | -34 | 1 | D | | | | | | | | | | | | | | |
5/3/22 19:03 | 4/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 3 | | 2 | D | | | | | | | | | | | | | | |
5/3/22 19:03 | 5/2/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -8 | 11.75 | 0 | -1 | -24 | 2 | D | | | | | | | | | | | | | | |
5/3/22 19:03 | 4/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 2 | 130 | 3 | D | | | | | | | | | | | | | | |
5/3/22 19:03 | 5/2/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -8 | 11.75 | 0 | -1 | -16 | 3 | D | | | | | | | | | | | | | | |
1/11/22 16:10 | 1/10/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 2 | 1.86 | 0 | 1 | 999% | 1 | D | | | | | | | | | | | | | | |
1/11/22 16:10 | 1/10/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -33 | 27.14 | 0 | -1 | -48 | 1 | D | | | | | | | | | | | | | | |
1/4/22 16:19 | 1/3/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 17 | 9.06 | 0 | 2 | 15 | 14 | D | | | | | | | | | | | | | | |
1/4/22 16:19 | 1/3/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -53 | 28.96 | 0 | -2 | -11 | 14 | D | | | | | | | | | | | | | | |
12/13/21 16:47 | 12/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 2 | 1.86 | 0 | 1 | 999% | 1 | D | | | | | | | | | | | | | | |
12/13/21 16:47 | 12/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -35 | 29.04 | 0 | -1 | -48 | 1 | D | | | | | | | | | | | | | | |
12/2/21 17:43 | 12/1/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 3 | 7.26 | 0 | 0 | 3 | 14 | D | | | | | | | | | | | | | | |
12/2/21 17:43 | 12/1/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -12 | 29.13 | 0 | 0 | -3 | 14 | D | | | | | | | | | | | | | | |
11/12/21 17:15 | 11/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 2 | 1.86 | 0 | 1 | 999% | 1 | D | | | | | | | | | | | | | | |
11/12/21 17:15 | 11/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -39 | 32.38 | 0 | -1 | -48 | 1 | D | | | | | | | | | | | | | | |
11/2/21 17:28 | 11/1/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 3 | 7.26 | 0 | 0 | 3 | 14 | D | | | | | | | | | | | | | | |
11/2/21 17:28 | 11/1/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -13 | 33.24 | 0 | 0 | -3 | 14 | D | | | | | | | | | | | | | | |
10/28/21 19:25 | 10/27/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 1 | 1.86 | 0 | 1 | 165 | 1 | D | | | | | | | | | | | | | | |
10/28/21 19:25 | 10/27/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -28 | 35.25 | 0 | -1 | -38 | 1 | D | | | | | | | | | | | | | | |
10/28/21 19:23 | 10/27/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 3 | 7.26 | 0 | 0 | 3 | 14 | D | | | | | | | | | | | | | | |
10/28/21 19:23 | 10/27/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -14 | 35.00 | 0 | 0 | -3 | 14 | D | | | | | | | | | | | | | | |
10/12/21 18:43 | 10/11/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 2 | 1.86 | 0 | 1 | 999% | 1 | D | | | | | | | | | | | | | | |
10/12/21 18:43 | 10/11/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -33 | 27.36 | 0 | -1 | -48 | 1 | D | | | | | | | | | | | | | | |
10/4/21 17:16 | 10/1/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 3 | 7.26 | 0 | 0 | 3 | 14 | D | | | | | | | | | | | | | | |
10/4/21 17:16 | 10/1/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -12 | 29.92 | 0 | 0 | -3 | 14 | D | | | | | | | | | | | | | | |
9/13/21 16:07 | 9/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 4 | 1.86 | 0 | 2 | | 1 | D | | | | | | | | | | | | | | |
9/13/21 16:07 | 9/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -72 | 35.93 | 0 | -2 | -61 | 1 | D | | | | | | | | | | | | | | |
9/8/21 17:08 | 9/7/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 6 | 1.86 | 0 | 3 | | 1 | D | | | | | | | | | | | | | | |
9/8/21 17:08 | 9/7/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -113 | 35.25 | 0 | -3 | -71 | 1 | D | | | | | | | | | | | | | | |
9/8/21 17:08 | 9/7/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 12 | 7.26 | 0 | 2 | 13 | 14 | D | | | | | | | | | | | | | | |
9/8/21 17:08 | 9/7/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -56 | 35.00 | 0 | -2 | -10 | 14 | D | | | | | | | | | | | | | | |
9/2/21 16:22 | 9/1/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 3 | 7.26 | 0 | 0 | 3 | 14 | D | | | | | | | | | | | | | | |
9/2/21 16:22 | 9/1/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -13 | 32.34 | 0 | 0 | -3 | 14 | D | | | | | | | | | | | | | | |
8/11/21 18:21 | 8/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 2 | 1.86 | 0 | 1 | | 1 | D | | | | | | | | | | | | | | |
8/11/21 18:21 | 8/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -36 | 29.87 | 0 | -1 | -60 | 1 | D | | | | | | | | | | | | | | |
8/11/21 18:20 | 8/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Beaurang Pierre | CA | O | Chief Bu | M.d | 8 | 1.11 | 0 | 8 | 7 | 121 | D | | | | | | | | | | | | | | |
8/11/21 18:20 | 8/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Beaurang Pierre | CA | O | Chief Bu | S.d | -224 | 29.86 | 0 | -8 | -6 | 121 | D | | | | | | | | | | | | | | |
8/3/21 17:39 | 8/2/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 3 | 7.26 | 0 | 0 | 3 | 14 | D | | | | | | | | | | | | | | |
8/3/21 17:39 | 8/2/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -12 | 31.21 | 0 | 0 | -3 | 14 | D | | | | | | | | | | | | | | |
7/21/21 17:34 | 7/20/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 2 | 1.86 | 0 | 1 | | 1 | D | | | | | | | | | | | | | | |
7/21/21 17:34 | 7/20/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -32 | 27.00 | 0 | -1 | -60 | 1 | D | | | | | | | | | | | | | | |
7/12/21 19:36 | 7/12/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Beaurang Pierre | CA | O | Chief Bu | M.d | 8 | 1.11 | 0 | 8 | 7 | 121 | D | | | | | | | | | | | | | | |
7/12/21 19:36 | 7/12/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Beaurang Pierre | CA | O | Chief Bu | S.d | -179 | 23.92 | 0 | -8 | -6 | 121 | D | | | | | | | | | | | | | | |
7/2/21 16:03 | 7/1/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 3 | 7.26 | 0 | 0 | 3 | 14 | D | | | | | | | | | | | | | | |
7/2/21 16:03 | 7/1/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -11 | 26.76 | 0 | 0 | -3 | 14 | D | | | | | | | | | | | | | | |
6/11/21 16:11 | 6/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 2 | 1.86 | 0 | 1 | | 1 | D | | | | | | | | | | | | | | |
6/11/21 16:11 | 6/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -35 | 29.40 | 0 | -1 | -60 | 1 | D | | | | | | | | | | | | | | |
6/11/21 16:10 | 6/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Beaurang Pierre | CA | O | Chief Bu | M.d | 8 | 1.11 | 0 | 8 | 7 | 121 | D | | | | | | | | | | | | | | |
6/11/21 16:10 | 6/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Beaurang Pierre | CA | O | Chief Bu | S.d | -220 | 29.37 | 0 | -8 | -6 | 121 | D | | | | | | | | | | | | | | |
6/2/21 16:49 | 6/1/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 3 | 7.26 | 0 | 0 | 3 | 14 | D | | | | | | | | | | | | | | |
6/2/21 16:49 | 6/1/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -11 | 27.74 | 0 | 0 | -3 | 14 | D | | | | | | | | | | | | | | |
5/11/21 19:58 | 5/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 2 | 1.86 | 0 | 1 | | 1 | D | | | | | | | | | | | | | | |
5/11/21 19:58 | 5/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -32 | 27.00 | 0 | -1 | -60 | 1 | D | | | | | | | | | | | | | | |
5/11/21 19:56 | 5/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Beaurang Pierre | CA | O | Chief Bu | M.d | 8 | 1.11 | 0 | 8 | 7 | 121 | D | | | | | | | | | | | | | | |
5/11/21 19:56 | 5/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Beaurang Pierre | CA | O | Chief Bu | S.d | -199 | 26.49 | 0 | -8 | -6 | 121 | D | | | | | | | | | | | | | | |
5/4/21 16:27 | 5/3/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 6 | 7.26 | 0 | 1 | 6 | 14 | D | | | | | | | | | | | | | | |
5/4/21 16:27 | 5/3/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -28 | 35.00 | 0 | -1 | -5 | 14 | D | | | | | | | | | | | | | | |
4/29/21 18:05 | 4/28/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 1 | 1.86 | 0 | 1 | 999% | 1 | D | | | | | | | | | | | | | | |
4/29/21 18:05 | 4/28/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -28 | 35.25 | 0 | -1 | -50 | 1 | D | | | | | | | | | | | | | | |
4/13/21 17:20 | 4/12/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 2 | 1.86 | 0 | 1 | | 1 | D | | | | | | | | | | | | | | |
4/13/21 17:20 | 4/12/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -33 | 27.20 | 0 | -1 | -60 | 1 | D | | | | | | | | | | | | | | |
4/13/21 17:19 | 4/12/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Beaurang Pierre | CA | O | Chief Bu | M.d | 8 | 1.02 | 0 | 8 | 7 | 121 | D | | | | | | | | | | | | | | |
4/13/21 17:19 | 4/12/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Beaurang Pierre | CA | O | Chief Bu | S.d | -205 | 27.28 | 0 | -8 | -6 | 121 | D | | | | | | | | | | | | | | |
4/6/21 16:04 | 4/5/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 3 | 7.26 | 0 | 0 | 3 | 14 | D | | | | | | | | | | | | | | |
4/6/21 16:04 | 4/5/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -14 | 35.00 | 0 | 0 | -3 | 14 | D | | | | | | | | | | | | | | |
4/2/21 17:22 | 4/1/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 3 | 7.26 | 0 | 0 | 3 | 14 | D | | | | | | | | | | | | | | |
4/2/21 17:22 | 4/1/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -13 | 31.55 | 0 | 0 | -3 | 14 | D | | | | | | | | | | | | | | |
3/25/21 19:23 | 3/25/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Beaurang Pierre | CA | O | Chief Bu | M.d | 4 | 0.8400 | 0 | 4 | 4 | 121 | D | | | | | | | | | | | | | | |
3/16/21 18:50 | 3/16/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 6 | 7.26 | 0 | 1 | 6 | 14 | D | | | | | | | | | | | | | | |
3/16/21 18:50 | 3/16/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -36 | 45.00 | 0 | -1 | -5 | 14 | D | | | | | | | | | | | | | | |
3/11/21 17:35 | 3/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 4 | 1.86 | 0 | 2 | | 1 | D | | | | | | | | | | | | | | |
3/11/21 17:35 | 3/10/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -83 | 41.27 | 0 | -2 | -71 | 1 | D | | | | | | | | | | | | | | |
3/9/21 16:04 | 3/8/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Beaurang Pierre | CA | O | Chief Bu | M.d | 6 | 0.8400 | 0 | 8 | 7 | 117 | D | | | | | | | | | | | | | | |
3/9/21 16:04 | 3/8/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Beaurang Pierre | CA | O | Chief Bu | S.d | -278 | 37.02 | 0 | -8 | -6 | 117 | D | | | | | | | | | | | | | | |
3/2/21 17:29 | 3/1/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 6 | 7.26 | 0 | 1 | 6 | 14 | D | | | | | | | | | | | | | | |
3/2/21 17:29 | 3/1/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -29 | 35.95 | 0 | -1 | -5 | 14 | D | | | | | | | | | | | | | | |
2/25/21 16:18 | 2/24/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 62 | 1.76 | 0 | 35 | | 0 | D | | | | | | | | | | | | | | |
2/25/21 16:18 | 2/24/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -1,413 | 39.90 | 0 | -35 | -100 | 0 | D | | | | | | | | | | | | | | |
2/23/21 18:04 | 2/22/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 6 | 1.10 | 0 | 5 | | 0 | D | | | | | | | | | | | | | | |
2/23/21 18:04 | 2/22/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -213 | 39.93 | 0 | -5 | -100 | 0 | D | | | | | | | | | | | | | | |
2/22/21 16:09 | 2/18/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 11 | 0.8400 | 0 | 14 | | 0 | D | | | | | | | | | | | | | | |
2/22/21 16:09 | 2/18/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -482 | 35.46 | 0 | -14 | -100 | 0 | D | | | | | | | | | | | | | | |
2/22/21 16:08 | 2/18/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 4 | 1.86 | 0 | 2 | | 0 | D | | | | | | | | | | | | | | |
2/22/21 16:08 | 2/18/21 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -72 | 35.88 | 0 | -2 | -100 | 0 | D | | | | | | | | | | | | | | |